SRS Capital Advisors »

Aldeyra Therapeutics shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Aldeyra Therapeutics (ALDX) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Aldeyra Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aldeyra Therapeutics held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aldeyra Therapeutics by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-09-30 $268k 51k 5.22
2025-03-31 $719 125 5.75
2024-12-31 $908 182 4.99
2024-09-30 $1.4k 266 5.39
2024-06-30 $880 266 3.31

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VOO)
Ishares Tr Ishs 1-5yr Invs (OEF)
First Tr Exchange-traded Wtr Etf (FDL)
American Centy Etf Tr Us Large Cap Vlu (KORP)
Dimensional Etf Trust Intl Core Equity (DFAI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Schwab Strategic Tr Us Tips Etf (SCHB)
Microsoft Corporation (MSFT)
First Tr Exchng Traded Fd Vi Smith Opport Fxd (FIXD)
First Tr Exchange Traded Risng Divd Achiv (FXN)
NVIDIA Corporation (NVDA)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
Spdr S&p 500 Etf Tr Tr Unit
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)

View all positions for SRS Capital Advisors

Top funds holding Aldeyra Therapeutics

Knoll Capital Management
Perceptive Advisors
BlackRock
Vanguard Group
Ardsley Advisory Partners
AQR Capital Management
D. E. Shaw & Co
Kingdon Capital Management
Geode Capital Management
Kennedy Capital Management
State Street Corporation
Jacobs Levy Equity Management
Acadian Asset Management
683 Capital Management
Morgan Stanley

View all funds holding Aldeyra Therapeutics